Files in this item
Tuberculosis Molecular Bacterial Load Assay reveals early delayed bacterial killing in patients with relapse
Item metadata
dc.contributor.author | Ntinginya, Nyanda Elias | |
dc.contributor.author | Bakuli, Abishek | |
dc.contributor.author | Mapamba, Daniel | |
dc.contributor.author | Sabiiti, Wilber | |
dc.contributor.author | Kibiki, Gibson | |
dc.contributor.author | Minja, Lilian Tina | |
dc.contributor.author | Kuchaka, Davis | |
dc.contributor.author | Reither, Klaus | |
dc.contributor.author | Phillips, Patrick | |
dc.contributor.author | Boeree, Martin J | |
dc.contributor.author | Gillespie, Stephen Henry | |
dc.contributor.author | Hoelscher, Michael | |
dc.contributor.author | Heinrich, Norbert | |
dc.contributor.author | PanACEA Consortium | |
dc.date.accessioned | 2022-07-28T10:30:14Z | |
dc.date.available | 2022-07-28T10:30:14Z | |
dc.date.issued | 2023-02-01 | |
dc.identifier | 280147052 | |
dc.identifier | 14f76917-5a5d-4270-9fdf-b0106da8eb40 | |
dc.identifier | 000826596100001 | |
dc.identifier | 85147783549 | |
dc.identifier.citation | Ntinginya , N E , Bakuli , A , Mapamba , D , Sabiiti , W , Kibiki , G , Minja , L T , Kuchaka , D , Reither , K , Phillips , P , Boeree , M J , Gillespie , S H , Hoelscher , M , Heinrich , N & PanACEA Consortium 2023 , ' Tuberculosis Molecular Bacterial Load Assay reveals early delayed bacterial killing in patients with relapse ' , Clinical Infectious Diseases , vol. 76 , no. 3 , ciac445 , pp. e990-e994 . https://doi.org/10.1093/cid/ciac445 | en |
dc.identifier.issn | 1058-4838 | |
dc.identifier.other | ORCID: /0000-0001-6537-7712/work/116597958 | |
dc.identifier.other | ORCID: /0000-0002-4742-2791/work/116598341 | |
dc.identifier.uri | https://hdl.handle.net/10023/25735 | |
dc.description | Funding: this work was supported by several funding agencies. The PanACEA MAMS study was funded by the European and Developing Countries Clinical Trials Partnership (EDCTP1); Grant No. IP.2007.32011.013, IP.2007.32011.012, and IP.2007.32011.011 as well as by the German Ministry of Education and Research (01KA0901). This analysis was funded by the German Center for Infection Research (DZIF); grant no. 02.702. | en |
dc.description.abstract | Bacterial killing in patients with tuberculosis (TB) relapse was compared to that in patients achieving cure, measured by TB molecular bacterial load assay (TB-MBLA) or mycobacteria growth indicator tube (MGIT) time to positivity (TTP). TB-MBLA in 4 relapsed patients was significantly different compared to 132 cured patients after 2 weeks of treatment; MGIT TTP showed a significant difference from week 8. | |
dc.format.extent | 5 | |
dc.format.extent | 454744 | |
dc.language.iso | eng | |
dc.relation.ispartof | Clinical Infectious Diseases | en |
dc.subject | Tuberculosis | en |
dc.subject | Biomarker | en |
dc.subject | Relapse | en |
dc.subject | Clinical trial | en |
dc.subject | QR Microbiology | en |
dc.subject | NDAS | en |
dc.subject | SDG 3 - Good Health and Well-being | en |
dc.subject | MCC | en |
dc.subject.lcc | QR | en |
dc.title | Tuberculosis Molecular Bacterial Load Assay reveals early delayed bacterial killing in patients with relapse | en |
dc.type | Journal article | en |
dc.contributor.institution | University of St Andrews. Infection and Global Health Division | en |
dc.contributor.institution | University of St Andrews. School of Medicine | en |
dc.contributor.institution | University of St Andrews. Sir James Mackenzie Institute for Early Diagnosis | en |
dc.contributor.institution | University of St Andrews. Centre for Biophotonics | en |
dc.contributor.institution | University of St Andrews. Global Health Implementation Group | en |
dc.contributor.institution | University of St Andrews. Gillespie Group | en |
dc.contributor.institution | University of St Andrews. Biomedical Sciences Research Complex | en |
dc.identifier.doi | 10.1093/cid/ciac445 | |
dc.description.status | Peer reviewed | en |
This item appears in the following Collection(s)
Items in the St Andrews Research Repository are protected by copyright, with all rights reserved, unless otherwise indicated.